Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence
1 other identifier
interventional
520
1 country
1
Brief Summary
The study assesses the potential of using computational models, specifically large language models, to simulate psychotherapeutic sessions, aiming to improve therapy outcomes and advance therapist training through innovative technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 3, 2025
CompletedFirst Posted
Study publicly available on registry
February 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedMay 22, 2026
May 1, 2026
7 months
February 3, 2025
May 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Simulation's Accuracy in generating Psychotherapeutic Dialogues
Assessment of the simulation's ability to accurately produce psychotherapeutic dialogues that adhere to the principles and techniques of motivational interviewing (MI), as determined by the average global scores of the Motivational Interviewing Treatment Integrity (MITI) code 4.2. The MITI code 4.2 includes various subscales, such as empathy and MI spirit, each scored on a scale from 1 to 5, with lower scores suggesting a need for improvement in MI delivery, while higher scores reflect stronger therapeutic skills and better patient outcomes.
12 months
Secondary Outcomes (9)
Number of Errors/Deviations
12 months
Metric of Verbal Content (Therapist)
12 months
Metric of Verbal Content (Patient)
12 months
Turn-takings
12 months
Improvement of Patient
12 months
- +4 more secondary outcomes
Study Arms (3)
High Levels of Common Therapeutic Factors
EXPERIMENTALIn this group, the patient-large language model (LLM) interacted with a therapist-LLM prompted to exhibit high levels of positive common factors.
Low Levels of Common Therapeutic Factors
EXPERIMENTALIn this group, the patient-large language model (LLM) interacted with a therapist-LLM prompted to exhibit low levels of positive common factors.
Transcripts of real intervention sessions
OTHERThis group consists of published transcripts of real intervention sessions, in which motivational interview techniques have been applied.
Interventions
The therapist large language model (LLM) is designed to show high levels of empathy, warmth, and genuineness. This setup aims to create a supportive and trusting therapeutic environment to improve patient engagement. High levels of these positive factors are linked to better psychotherapy outcomes and a stronger therapist-patient relationship.
The therapist LLM for this group is designed to show low levels of empathy, warmth, and genuineness. This setup aims to examine how a less supportive and empathetic therapist affects psychotherapy sessions. Lower levels of these positive behaviors can lead to reduced patient engagement and a weaker therapist-patient relationship, potentially hindering therapy outcomes.
Motivational interviewing techniques as applied during the sessions on which the transcripts are based.
Eligibility Criteria
You may qualify if:
- Simulation of psychotherapy sessions of conversations between an adult person presenting with a mental or behavioral health problem and a psychotherapist using large language models and 8 real-world transcripts
You may not qualify if:
- Simulation protocols with severe simulation errors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- RWTH Aachen Universitycollaborator
- University of Baselcollaborator
- University of Triercollaborator
Study Sites (1)
University Hospital Basel
Basel, 4031, Switzerland
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Gunther Meinlschmidt, Prof. Dr.
University Hospital and University of Basel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2025
First Posted
February 6, 2025
Study Start
February 1, 2025
Primary Completion
August 31, 2025
Study Completion
August 31, 2025
Last Updated
May 22, 2026
Record last verified: 2026-05